The stem cell hard sell: Report from a clinic’s patient recruitment seminar

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

The growing direct-to-consumer, stem cell clinic industry in the U.S. uses a number of strategies for patient recruitment, including self-styled educational seminars, which may reach thousands of members of the public annually. Here I report on a first-hand experience at such a seminar that I recently attended. Numerous specific medical claims were made at the seminar: no potential for rejection; no side effects, including no pain; proven efficacy for a variety of conditions, including in particular arthritis and pain; and U.S. Food and Drug Administration approval. I discuss the potential impact of these kinds of seminars on the public and on the stem cell field.

Original languageEnglish (US)
Pages (from-to)14-16
Number of pages3
JournalStem cells translational medicine
Volume6
Issue number1
DOIs
StatePublished - Jan 1 2017

ASJC Scopus subject areas

  • Developmental Biology
  • Cell Biology

Fingerprint Dive into the research topics of 'The stem cell hard sell: Report from a clinic’s patient recruitment seminar'. Together they form a unique fingerprint.

  • Cite this